A New Immunosuppressive Therapy for Very Severe Aplastic Anemia in Children with Autoantibodies
Sign Up to like & getrecommendations! Published in 2022 at "Current Medical Science"
DOI: 10.1007/s11596-022-2519-2
Abstract: At present, a number of very severe aplastic anemia (VSAA) patients cannot receive hematopoietic stem cell transplantation (HSCT) or standard immunosuppressive therapy (IST) due to the high cost of therapy, shortage of sibling donors, and… read more here.
Keywords: vsaa patients; csa hdp; therapy; immunosuppressive therapy ... See more keywords